Parenteral Drugs (India) Share PriceParenteral Drugs (India)

₹2.9
0.05 (1.75%)
As on 25 September, 2023 | 21:26 BSE: 524689 NSE: PDPLISIN: INE904D01019

Parenteral Drugs (India) Performance

Day Range

  • Low 2.7
  • High 2.9
2.9

52 Week Range

  • Low 2.7
  • High 4.8
2.9
  • Open Price2.7
  • Previous Close2.85
  • Volume1063

Start SIP in Parenteral Drugs (India)

Start SIP

Parenteral Drugs (India) Share Price

  • Over 1 Month -4.92%
  • Over 3 Month -7.94%
  • Over 6 Month -27.5%
  • Over 1 Year -18.31%

Parenteral Drugs (India) Key Statistics

P/E Ratio -0.1
PEG Ratio -0
Market Cap Cr 9
Price to Book Ratio -0
EPS -43.1
Dividend 0
Relative Strength Index 36.04
Money Flow Index 3.73
MACD Signal -0.2
Average True Range 0.15

Parenteral Drugs (India) Investment Rating

  • Master Rating:
  • Parenteral Drugs India has an operating revenue of Rs. 8.50 Cr. on a trailing 12-month basis. An annual revenue de-growth of -30% needs improvement, Pre-tax margin of -1284% needs improvement, NULL It is currently FORMING a base in its weekly chart and is trading around 39% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 44 which is a POOR score indicating inconsistency in earnings, a RS Rating of 8 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 103 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Parenteral Drugs (India) Financials
IndicatorMar 2022
Oper Rev Qtr Cr 2
Operating Expenses Qtr Cr 8
Operating Profit Qtr Cr -6
Depreciation Qtr Cr 27
Interest Qtr Cr 0
Tax Qtr Cr -5
Net Profit Qtr Cr 24
IndicatorMar 2022
Total Revenue Annual Cr 9
Operating Expenses Annual Cr 24
Operating Profit Annual in Cr -15
Depreciation Cr 40
Interest Annual Cr 106
Tax Annual Cr -33
Net Profit Annual Cr -76
IndicatorMar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2022
Total ShareHolders Funds Annual Cr -824
Fixed Assets Annual Cr 205
Total Non Current Assets Annual Cr 416
Total Current Assets Annual Cr 66
Total Assets Annual Cr 483
IndicatorMar 2022
Book Value Per Share Annual Rs -276
ROE Annual % 0
ROCE Annual % 8
Total Debt to Total Equity Annual -
EBDIT Annual Margin % -176
IndicatorMar 2022
Oper Rev Qtr Cr 2
Operating Expenses Qtr Cr 8
Operating Profit Qtr Cr -6
Depreciation Qtr Cr 27
Interest Qtr Cr 0
Tax Qtr Cr -5
Net Profit Qtr Cr 24
IndicatorMar 2022
Total Revenue Annual Cr 9
Operating Expenses Annual Cr 24
Operating Profit Annual in Cr -15
Depreciation Cr 40
Interest Annual Cr 106
Tax Annual Cr -33
Net Profit Annual Cr -76
IndicatorMar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2022
Total ShareHolders Funds Annual Cr -824
Fixed Assets Annual Cr 205
Total Non Current Assets Annual Cr 417
Total Current Assets Annual Cr 67
Total Assets Annual Cr 484
IndicatorMar 2022
Book Value Per Share Annual Rs -276
ROE Annual % 0
ROCE Annual % 8
Total Debt to Total Equity Annual -
EBDIT Annual Margin % -176

Parenteral Drugs (India) Technicals

EMA & SMA

Current Price
₹2.9
0.05 (1.75%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹3.24
  • 50 Day
  • ₹3.47
  • 100 Day
  • ₹3.54
  • 200 Day
  • ₹3.72
  • 20 Day
  • ₹3.27
  • 50 Day
  • ₹3.59
  • 100 Day
  • ₹3.6
  • 200 Day
  • ₹3.48

Parenteral Drugs (India) Resistance and Support

PIVOT
₹2.84
Resistance
First Resistance ₹2.97
Second Resistance ₹3.04
Third Resistance ₹3.17
RSI 36.04
MFI 3.73
MACD Single Line -0.2
MACD -0.22
Support
First Resistance ₹2.77
Second Resistance ₹2.64
Third Resistance ₹2.57

Parenteral Drugs (India) Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day
Week
1 Month
6 Month 448 44,843 100

Parenteral Drugs (India) Result Highlights

Parenteral Drugs (India) Synopsis

NSE-Medical-Diversified

Parenteral Drugs is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 12.17 Cr. and Equity Capital is Rs. 29.82 Cr. for the Year ended 31/03/2021. Parenteral Drugs (India) Ltd. is a Public Limited Listed company incorporated on 13/12/1983 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24100MH1983PLC126481 and registration number is 126481.
Market Cap 9
Sales 8
Shares in Float 0.81
No of funds
Yield
Book Value -0.02
U/D Vol ratio 0.2
LTDebt / Equity
Alpha -0.35
Beta 0.53

Parenteral Drugs (India)

Owner Name

Parenteral Drugs (India) Management

Name Designation
Mr. Manohar Lal Gupta Chairman & Non-Exe.Director
Mr. Vinod Kumar Gupta Managing Director & CFO
Mr. Govind Das Garg Whole Time Director
Mr. Dharam Pal Khanna Ind. Non-Executive Director
Mr. Dilip Kumar Sinha Ind. Non-Executive Director
Mrs. Deepali Garhewal Ind. Non-Executive Director
Mr. Manish Verma Ind. Non-Executive Director
Mr. Anil Mittal Non Executive Director

Parenteral Drugs (India) Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Parenteral Drugs (India) Corporate Action

Date Purpose Remarks
2022-05-30 Audited Results & Others Inter alia, to consider : The shifting of registered office of the Company within local limits of the city.
2022-02-14 Quarterly Results
2022-02-02 Others inter alia, To consider appointment of Independent Director and to consider sale, lease or disposal of the whole or substantially the whole of the undertaking of the Company.
2021-11-12 Quarterly Results
2021-08-10 Quarterly Results
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

Parenteral Drugs (India) FAQs

What is Share Price of Parenteral Drugs (India) ?

Parenteral Drugs (India) share price is ₹2 As on 25 September, 2023 | 21:12

What is the Market Cap of Parenteral Drugs (India) ?

The Market Cap of Parenteral Drugs (India) is ₹8.6 Cr As on 25 September, 2023 | 21:12

What is the P/E ratio of Parenteral Drugs (India) ?

The P/E ratio of Parenteral Drugs (India) is -0.1 As on 25 September, 2023 | 21:12

What is the PB ratio of Parenteral Drugs (India) ?

The PB ratio of Parenteral Drugs (India) is -0 As on 25 September, 2023 | 21:12

Q2FY23